Dive Brief:
CMS has issued guidance to stop private group health plans from denying COVID-19 testing through the use of medical screening criteria for asymptomatic individuals with insurance coverage.
Congress required comprehensive health plans to cover COVID-19 tests without cost sharing, prior authorization or medical management last year, only for guidance to create uncertainty about the rules. President Joe Biden sought to clarify the situation in an executive order shortly after taking office.
CMS has built upon the order with guidance that details when testing needs coverage. American Clinical Laboratory Association, a laboratory trade group representing Quest Diagnostics and LabCorp, praised the move as decisive action that takes critical steps to close coverage gaps and protect patient access to COVID-19 testing.
Dive Brief:
A trade group representing laboratories including LabCorp and Quest Diagnostics has asked President Joe Biden to make more money available to test uninsured people for COVID-19.
The federal government is currently supporting the testing of uninsured people through a $2 billion fund. Yet the fund is almost depleted, leading the American Clinical Laboratory Association to write to Biden to request more money.
ACLA also said its members have seen health plans deny more than 1 million COVID-19 PCR tests since June and coverage uncertainty has created barriers for accessing diagnostics. The trade group wants Biden to close testing coverage loopholes to ensure access to COVID-19 diagnostics.
FDA lays groundwork for variant-focused vaccines
Presented by Pharmaceutical Care Management Association
With help from Emily Martin, Brianna Ehley
On Tap
and urges manufacturers to study options. Today: House hearing on Covid vaccines
plus a big J&J production pledge. This week: HHS nominees at that Senate
potentially clearing the way for an FDA pick.
A message from Pharmaceutical Care Management Association:
The Biden Administration postponed the effective date for the Medicare rebate rule until 2023. Despite the delay, uncertainty remains. The cleanest path forward to avoid disruption to Part D, caused by jarring monthly premium increases, is for Congress to quickly repeal the rebate rule outright.
Meticore Reviews 2021: Urgent Report Exposed by Researched Reviews
Meticore Reviews 2021 Update – New Facts Released Regarding Meticore Side Effects, Complaints, Price, Where to Buy at the Lowest Price and Meticore Ingredients.
Philadelphia, PA, Feb. 18, 2021 (GLOBE NEWSWIRE) Meticore Reviews: Groundbreaking New Meticore Reviews Report Gives Important Information All Consumers Must Know.
MUST SEE:
Researched Reviews (an Independent Research Group) Reports Their Latest Findings:
Meticore Report
What is Meticore? How to Use Meticore? Does Meticore Really Work? Is Meticore Amazon legitimate?
Please Note: This report is not meant to treat or diagnose any illness. It is written for informational purposes only. If you have any health concern at all, please see a licensed healthcare professional. Researched Reviews LLC provides independent reviews only and is not the manufacturer of Meticore.
POLITICO
Get the Prescription Pulse newsletter
Email
Sign Up
By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Presented by Pharmaceutical Care Management Association
With David Lim, Brianna Ehley and Emily Martin
On Tap
as Biden’s commissioner search continues. Congressional probe highlights plasma pressure
amid other allegations. AstraZeneca shot snagged on production lags and variant challenges.